GOLDEN, Colo. – February 26, 2015– Today, PharmaJet, the maker of innovative, needle-free injector technology, announced the release of survey data demonstrating consumer satisfaction with the PharmaJet Needle-Free Injector for seasonal flu vaccinations.
The surveys asked consumers who had just received a PharmaJet Needle-Free flu shot how satisfied they were with the experience, how likely they were to choose a PharmaJet Needle-Free flu shot again next year and how likely they would be to recommend a needle-free flu shot to family and friends. With nearly 1,500 surveys completed, the results are as follows:
- 96% were satisfied with the experience.
- 93% would choose it again.
- 92% would recommend the needle-free flu shot to family and friends.
“The survey results point to the acceptance and preference for a needle-free flu shot option and represent a significant opportunity to expand influenza immunizations. In environments like pharmacies it provides the ability to attract new customers, particularly those with a reluctance to get injections with needles, which can subsequently increase store traffic,” said Ron Lowy, Chairman and CEO of PharmaJet, Inc. “The PharmaJet Needle-Free flu shot is safe for health care providers and patients, quick to administer, and the survey confirms that most patients would choose it again. We believe that offering a needle-free option can significantly increase flu shot compliance, as a recent report showed that nearly one-quarter of individuals avoid being vaccinated because they don’t like needles.”
This data was collected from surveys that were given to patients who had just received a flu shot with the PharmaJet Needle-Free Injector at select retail pharmacies, a university flu shot campaign event, a public health organization and a government research organization. Full survey results are available here.
About PharmaJet, Inc.
Based in Golden, Colorado, PharmaJet was founded with the goal of reducing the use of medical needles throughout the world. PharmaJet’s innovative Stratis® Injector has U.S. FDA 510(k) marketing clearance, CE Mark and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously. The PharmaJet Needle-Free Injector is easy-to-use and eliminates needlestick injuries, needle re-use and cross contamination, and helps reduce “sharps” waste disposal.